CHIN HO PAK: Open Payments
NPI 1386721470 · MONROE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 47 payments from 9 companies in 2025. Trend: 2023 $959 · 2024 $846 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $259 |
| Neurocrine BioSciences, Inc. | 12 | $246 |
| E.R. Squibb & Sons, L.L.C. | 9 | $163 |
| Alkermes, Inc. | 4 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lundbeck LLC | 2 | $43 |
| ABBVIE INC. | 2 | $35 |
Products named: INVEGA SUSTENNA, INGREZZA, COBENFY, ARISTADA, REXULTI, CAPLYTA, VRAYLAR, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
